Tune in to the latest EMJ Webinar, featuring three of the Biomedical Alliance in Europe’s most valued members, who join host Jonathan Sackier to discuss the aims of the Alliance, their role in continuing medical education (CME), and industry influence in research today.
Elizabeth Macintyre, President of the Alliance; Lino Gonçalves, Board Member; and Wilfried Ellmeier, former President of the Alliance, dive into translational research, industry influence on education, and regulation in healthcare.
Themes covered include:
- (05:45)-Prioritising translational research
- (11:53)-Industry influence on CME
- (27:56)-European core curricula
- (36:13)-Regulatory challenges
Elizabeth Macintyre
President, Biomedical Alliance in Europe; Université Paris Cité, FranceMacintyre headed haematology diagnostics at Necker-Enfants Malades from 1998-2018 and now co-directs the INSERM Normal and Pathological Lymphoid Differentiation Team at Université Paris Cité. She was European Hematology Association (EHA) President in 2021–2023.
Wilfried Ellmeier
Former President, Biomedical Allience in Europe; Medical University of Vienna, AustriaEllmeier is corresponding member of the Austrian Academy of Sciences and a scientific board member of the Austrian Science Fund. He was President of the Biomedical Alliance in Europe in 2020–2021.
Lino Gonçalves
Board Member, Biomedical Alliance in Europe; Coimbra University Hospital Centre, PortugalHaving worked in several European committees and institutions related to education, accreditation, and certification, and with hundreds of publications to his name, Lino is also Co-Director of the Harvard Medical School Clinical Research Training Program in Portugal (PTCSRT).
